These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15151921)

  • 1. Positive clinical trials: understand the control group before implementing the result.
    Parshuram CS; Kavanagh BP
    Am J Respir Crit Care Med; 2004 Aug; 170(3):223-6. PubMed ID: 15151921
    [No Abstract]   [Full Text] [Related]  

  • 2. Historical controls, data banks, and randomized trials in clinical research: a review.
    Fleming TR
    Cancer Treat Rep; 1982 May; 66(5):1101-5. PubMed ID: 7083214
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluating treatment effect].
    Lindh J
    Lakartidningen; 2013 Jan 23-29; 110(4):159-62. PubMed ID: 23427725
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethical problems in the use of controls in medical research.
    Hay P
    N Z Med J; 1988 Sep; 101(854):608-10. PubMed ID: 3173856
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal Bayesian design for patient selection in a clinical study.
    Buzoianu M; Kadane JB
    Biometrics; 2009 Sep; 65(3):953-61. PubMed ID: 19021600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues.
    Sankoh AJ; D'Agostino RB; Huque MF
    Stat Med; 2003 Oct; 22(20):3133-50. PubMed ID: 14518019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical decision rules in radiology.
    Reed MH
    Acad Radiol; 2006 May; 13(5):562-5. PubMed ID: 16627196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myth of evidence-based medicine for bipolar disorder.
    Post RM
    Expert Rev Neurother; 2009 Sep; 9(9):1271-3. PubMed ID: 19769442
    [No Abstract]   [Full Text] [Related]  

  • 10. Real-life research.
    Lipman EL; Boyle MH
    Am J Psychiatry; 2003 Feb; 160(2):387; author reply 387. PubMed ID: 12562598
    [No Abstract]   [Full Text] [Related]  

  • 11. Methodological issues in clinical trials of drug and behavior therapies.
    Holroyd KA; Powers SW; Andrasik F
    Headache; 2005 May; 45(5):487-92. PubMed ID: 15953265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Khan OA; Tselis A; Boster A
    Neurology; 2009 Jun; 72(24):2134; author reply 2134-5. PubMed ID: 19528523
    [No Abstract]   [Full Text] [Related]  

  • 13. Principles and pitfalls of clinical trials design.
    Jeffcoat MK
    J Periodontol; 1992 Dec; 63(12 Suppl):1045-51. PubMed ID: 1479524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Trial Design in Neuroendocrine Tumors.
    Halperin DM; Yao JC
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):209-17. PubMed ID: 26614378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10 Years with ICH E10: Choice of Control Groups.
    Rockhold FW; Enas GG
    Pharm Stat; 2011; 10(5):407-9. PubMed ID: 21928353
    [No Abstract]   [Full Text] [Related]  

  • 16. The statistical comparison of clinical trials.
    Schooler NR
    J Clin Psychiatry; 2001; 62 Suppl 9():35-7; discussion 38-9. PubMed ID: 11379830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Design of clinical studies: new approaches beyond randomised investigations].
    Nienaber CA; Willems S; Erdmann E
    Dtsch Med Wochenschr; 2014 Sep; 139(39):1921-2. PubMed ID: 25225859
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome measures in multiple sclerosis clinical trials.
    Andersson PB; Goodkin DE
    Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating patient-based outcome measures for use in clinical trials.
    Fitzpatrick R; Davey C; Buxton MJ; Jones DR
    Health Technol Assess; 1998; 2(14):i-iv, 1-74. PubMed ID: 9812244
    [No Abstract]   [Full Text] [Related]  

  • 20. Are surrogate endpoints useful in clinical studies?
    Amdal CD; Bjordal K
    Tidsskr Nor Laegeforen; 2014 Jun; 134(11):1128-9. PubMed ID: 24939776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.